This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
World Health Organization. Obesity and overweight. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.World Health Organizationhttps://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.Search in Google Scholar
Fasano A. Gut permeability, obesity, and metabolic disorders: Who is the chicken and who is the egg? Am J Clin Nutr. 2017; 105: 3–4.FasanoAGut permeability, obesity, and metabolic disorders: Who is the chicken and who is the egg?20171053410.3945/ajcn.116.14833828003208Search in Google Scholar
Ahmad R, Sorrell MF, Batra SK, Dhawan P, Singh AB. Gut permeability and mucosal inflammation: Bad, good or context dependent. Mucosal Immunol. 2017; 10: 307–317.AhmadRSorrellMFBatraSKDhawanPSinghABGut permeability and mucosal inflammation: Bad, good or context dependent20171030731710.1038/mi.2016.128617134828120842Search in Google Scholar
Janczy A, Kochan Z, Małgorzewicz S. Endotoxemia and intestinal barrier disorders associated with overweight and obesity. Post Mikrobiol Adv Microbiol. 2019; 58: 427–432.JanczyAKochanZMałgorzewiczSEndotoxemia and intestinal barrier disorders associated with overweight and obesity20195842743210.21307/PM-2019.58.4.427Search in Google Scholar
Caricilli AM, Castoldi A, Câmara NO. Intestinal barrier: A gentlemen’s agreement between microbiota and immunity. World J Gastrointest Pathophysiol. 2014; 5: 18–32.CaricilliAMCastoldiACâmaraNOIntestinal barrier: A gentlemen’s agreement between microbiota and immunity20145183210.4291/wjgp.v5.i1.18402451724891972Search in Google Scholar
Tokarz-Deptuła B, Śliwa-Dominiak J, Adamiak M, Bąk K, Deptuła W. Bakterie komensalne a odporność układu pokarmowego, oddechowego i moczowo-płciowego. Postepy Hig Med Dosw. 2016; 70, 599–609.Tokarz-DeptułaBŚliwa-DominiakJAdamiakMBąkKDeptułaWBakterie komensalne a odporność układu pokarmowego, oddechowego i moczowo-płciowego20167059960910.5604/17322693.120495427333930Search in Google Scholar
Węgrzyn D, Adamek K, Łoniewska B. Structure of the intestinal barrier. Pomeranian J Life Sci. 2017; 63: 6–9.WęgrzynDAdamekKŁoniewskaBStructure of the intestinal barrier20176369Search in Google Scholar
Lee SH. Intestinal permeability regulation by tight junction: Implication on inflammatory bowel diseases. Intest Res. 2015; 9100: 11–18LeeSHIntestinal permeability regulation by tight junction: Implication on inflammatory bowel diseases20159100111810.5217/ir.2015.13.1.11431621625691839Search in Google Scholar
Casselbrant A, Elias E, Fändriks L, Wallenius V. Expression of tight-junction proteins in human proximal small intestinal mucosa before and after Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis. 2015; 11: 45–53.CasselbrantAEliasEFändriksLWalleniusVExpression of tight-junction proteins in human proximal small intestinal mucosa before and after Roux-en-Y gastric bypass surgery201511455310.1016/j.soard.2014.05.00925264329Search in Google Scholar
Suzuki T. Regulation of intestinal epithelial permeability by tight junctions. Cell Mol Life Sci. 2013; 70: 631–659.SuzukiTRegulation of intestinal epithelial permeability by tight junctions20137063165910.1007/s00018-012-1070-x22782113Search in Google Scholar
Umeda K, Matsui T, Nakayama M, Furuse K, Sasaki H, Furuse M, Tsukita S. Establishment and characterization of cultured epithelial cells lacking expression of ZO-1. J Biol Chem. 2004; 279: 44785–44794.UmedaKMatsuiTNakayamaMFuruseKSasakiHFuruseMTsukitaSEstablishment and characterization of cultured epithelial cells lacking expression of ZO-12004279447854479410.1074/jbc.M40656320015292177Search in Google Scholar
Żak-Gołąb A, Kocełak P, Aptekorz M, Zientara M, Juszczyk L, Martirosian G, Chudek J, Olszanecka-Glinianowicz M. Gut microbiota, micro-inflammation, metabolic profile, and zonulin concentration in obese and normal weight subjects. Int J Endocrinol. 2013; 2013: 674106.Żak-GołąbAKocełakPAptekorzMZientaraMJuszczykLMartirosianGChudekJOlszanecka-GlinianowiczMGut microbiota, micro-inflammation, metabolic profile, and zonulin concentration in obese and normal weight subjects2013201367410610.1155/2013/674106373264423970898Search in Google Scholar
Kojima T, Murata M, Go M, Spray DC, Sawada N. Connexins induce and maintain tight junctions in epithelial cells. J Membrane Biol. 2007; 217: 13–19.KojimaTMurataMGoMSprayDCSawadaNConnexins induce and maintain tight junctions in epithelial cells2007217131910.1007/s00232-007-9021-417568974Search in Google Scholar
Pendyala S, Walker JM, Holt PR. A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology, 2012; 142: 1100–1101.e2.PendyalaSWalkerJMHoltPRA high-fat diet is associated with endotoxemia that originates from the gut201214211001101.e210.1053/j.gastro.2012.01.034397871822326433Search in Google Scholar
Raetz CRH, Whitfield C. Lipopolysaccharide endotoxins. Annu Rev Biochem. 2002; 71: 635–700.RaetzCRHWhitfieldCLipopolysaccharide endotoxins20027163570010.1146/annurev.biochem.71.110601.135414256985212045108Search in Google Scholar
Gnauck A, Lentle RG, Kruger MC. The characteristics and function of bacterial lipopolysaccharides and their endotoxic potential in humans. Int Rev Immunol. 2016; 35: 189–218.GnauckALentleRGKrugerMCThe characteristics and function of bacterial lipopolysaccharides and their endotoxic potential in humans20163518921810.3109/08830185.2015.108751826606737Search in Google Scholar
Maldonado RF, Sá-Correia I, Valvano MA. Lipopolysaccharide modification in Gram-negative bacteria during chronic infection. FEMS Microbiol Rev. 2016; 40: 480–493.MaldonadoRFSá-CorreiaIValvanoMALipopolysaccharide modification in Gram-negative bacteria during chronic infection20164048049310.1093/femsre/fuw007493122727075488Search in Google Scholar
Wachowicz B, Saluk-Juszczak J. Aktywność prozapalna lipopolisacharydu. Post Bioch. 2015; 51, 280–287.WachowiczBSaluk-JuszczakJAktywność prozapalna lipopolisacharydu201551280287Search in Google Scholar
Magne F, Gotteland M, Gauthier L, Zazueta A, Pesoa S, Navarrete P, Balamurugan R. The firmicutes/bacteroidetes ratio: A relevant marker of gut dysbiosis in obese patients? Nutrients, 2020; 12: 1474.MagneFGottelandMGauthierLZazuetaAPesoaSNavarretePBalamuruganRThe firmicutes/bacteroidetes ratio: A relevant marker of gut dysbiosis in obese patients?202012147410.3390/nu12051474728521832438689Search in Google Scholar
Garrett WS. Bacteroides, Prevotella, Porphyromonas, and Fusobacterium Species (and Other Medically Important Anaerobic Gram-Negative Bacilli). In: Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 2014; 2: 2773–2780.GarrettWSBacteroides, Prevotella, Porphyromonas, and Fusobacterium Species (and Other Medically Important Anaerobic Gram-Negative Bacilli)In:2014227732780Search in Google Scholar
Ghoshal S, Witta J, Zhong J, de Villiers W, Eckhardt E. Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res. 2009; 50: 90–97.GhoshalSWittaJZhongJde VilliersWEckhardtEChylomicrons promote intestinal absorption of lipopolysaccharides200950909710.1194/jlr.M800156-JLR20018815435Search in Google Scholar
Tuomi K, Logomarsino JV. Bacterial lipopolysaccharide, lipopolysaccharide-binding protein, and other inflammatory markers in obesity and after bariatric surgery. Metab Syndr Relat Disord. 2016; 14: 279–288.TuomiKLogomarsinoJVBacterial lipopolysaccharide, lipopolysaccharide-binding protein, and other inflammatory markers in obesity and after bariatric surgery20161427928810.1089/met.2015.017027228236Search in Google Scholar
Huang TT, Lai JB, Du YL, Xu Y, Ruan LM, Hu SH. Current understanding of gut microbiota in mood disorders: An update of human studies. Front. Genet., 2019; 10: 98.HuangTTLaiJBDuYLXuYRuanLMHuSHCurrent understanding of gut microbiota in mood disorders: An update of human studies2019109810.3389/fgene.2019.00098638972030838027Search in Google Scholar
Laugerette F, Vors C, Peretti N, Michalski MC. Complex links between dietary lipids, endogenous endotoxins and metabolic inflammation. Biochimie, 2011; 93: 39–45.LaugeretteFVorsCPerettiNMichalskiMCComplex links between dietary lipids, endogenous endotoxins and metabolic inflammation201193394510.1016/j.biochi.2010.04.01620433893Search in Google Scholar
Donnenberg MS. Enterobacteriaceae. In: Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 2014; 2: 2503–2517.DonnenbergMSEnterobacteriaceaeIn:2014225032517Search in Google Scholar
Nighot M, Al-Sadi R, Guo S, Rawat M, Nighot P, Watterson MD, Ma TY. Lipopolysaccharide-induced increase in intestinal epithelial tight permeability is mediated by Toll-like receptor 4/myeloid differentiation primary response 88 (MyD88) activation of myosin light chain kinase expression. Am J Pathol. 2017; 187: 2698–2710.NighotMAl-SadiRGuoSRawatMNighotPWattersonMDMaTYLipopolysaccharide-induced increase in intestinal epithelial tight permeability is mediated by Toll-like receptor 4/myeloid differentiation primary response 88 (MyD88) activation of myosin light chain kinase expression20171872698271010.1016/j.ajpath.2017.08.005571809629157665Search in Google Scholar
Guo S, Nighot M, Al-Sadi R, Alhmoud T, Nighot P, Ma TY. Lipopolysaccharide regulation of intestinal tight junction permeability is mediated by TLR4 signal transduction pathway activation of FAK and MyD88. J Immunol. 2015; 195: 4999–5010.GuoSNighotMAl-SadiRAlhmoudTNighotPMaTYLipopolysaccharide regulation of intestinal tight junction permeability is mediated by TLR4 signal transduction pathway activation of FAK and MyD8820151954999501010.4049/jimmunol.1402598463723726466961Search in Google Scholar
Cao S, Zhang Q, Wang C, Wu H, Jiao L, Hong Q, Hu C. LPS challenge increased intestinal permeability, disrupted mitochondrial function and triggered mitophagy of piglets. Innate Immun. 2018; 24: 221–230.CaoSZhangQWangCWuHJiaoLHongQHuCLPS challenge increased intestinal permeability, disrupted mitochondrial function and triggered mitophagy of piglets20182422123010.1177/1753425918769372683092129642727Search in Google Scholar
Fan K, Lin L, Ai Q, Wan J, Dai J, Liu G, Tang L, Yang Y, Ge P, Jiang R, Zhang L. Lipopolysaccharide-induced dephosphorylation of AMPK-activated protein kinase potentiates inflammatory injury via repression of ULK1-dependent autophagy. Front Immunol. 2018; 9: 1464.FanKLinLAiQWanJDaiJLiuGTangLYangYGePJiangRZhangLLipopolysaccharide-induced dephosphorylation of AMPK-activated protein kinase potentiates inflammatory injury via repression of ULK1-dependent autophagy20189146410.3389/fimmu.2018.01464602664829988556Search in Google Scholar
Przewłócka K, Folwarski M, Kaźmierczak-Siedlecka K, SkoniecznaŻydeck K, Kaczor JJ. Gut-muscle axis exists and may affect skeletal muscle adaptation to training. Nutrients, 2020; 12: 1451.PrzewłóckaKFolwarskiMKaźmierczak-SiedleckaKSkoniecznaŻydeckKKaczorJJGut-muscle axis exists and may affect skeletal muscle adaptation to training202012145110.3390/nu12051451728519332443396Search in Google Scholar
Raulien N, Friedrich K, Strobel S, Rubner S, Baumann S, von Bergen M, Körner A, Krueger M, Rossol M, Wagner U. Fatty acid oxidation compensates for lipopolysaccharide-induced Warburg effect in glucose-deprived monocytes. Front. Immunol., 2017; 8: 609.RaulienNFriedrichKStrobelSRubnerSBaumannSvon BergenMKörnerAKruegerMRossolMWagnerUFatty acid oxidation compensates for lipopolysaccharide-induced Warburg effect in glucose-deprived monocytes2017860910.3389/fimmu.2017.00609544703928611773Search in Google Scholar
Silwal P, Kim JK, Yuk JM, Jo EK. AMP-activated protein kinase and host defense against infection. Int J Mol Sci. 2018; 19: 3495.SilwalPKimJKYukJMJoEKAMP-activated protein kinase and host defense against infection201819349510.3390/ijms19113495627499030404221Search in Google Scholar
Guevara-Cruz M, Godinez-Salas ET, Sanchez-Tapia M, Torres-Villalobos G, Pichardo-Ontiveros E, Guizar-Heredia R, Arteaga-Sanchez L, Gamba G, Mojica-Espinosa R, Schcolnik-Cabrera A, et al. Genistein stimulates insulin sensitivity through gut microbiota reshaping and skeletal muscle AMPK activation in obese subjects. BMJ Open Diabetes Res Care. 2020; 8: e000948.Guevara-CruzMGodinez-SalasETSanchez-TapiaMTorres-VillalobosGPichardo-OntiverosEGuizar-HerediaRArteaga-SanchezLGambaGMojica-EspinosaRSchcolnik-CabreraAGenistein stimulates insulin sensitivity through gut microbiota reshaping and skeletal muscle AMPK activation in obese subjects20208e00094810.1136/bmjdrc-2019-000948706408532152146Search in Google Scholar
Sun X, Zhu MJ. AMP-activated protein kinase: A therapeutic target in intestinal diseases. Open Biol. 2017; 7: 170104.SunXZhuMJAMP-activated protein kinase: A therapeutic target in intestinal diseases2017717010410.1098/rsob.170104557744828835570Search in Google Scholar
Zachorska-Markiewicz B, Kocełak P. Rola układu kannabinoidowego w regulacji poboru pokarmu. Endokrynol Otył Zab Przem Mat. 2005; 1: 12–17.Zachorska-MarkiewiczBKocełakPRola układu kannabinoidowego w regulacji poboru pokarmu200511217Search in Google Scholar
Dipatrizio NV. Endocannabinoids in the gut. Cannabis Cannabinoid Res. 2016; 1: 67–77.DipatrizioNVEndocannabinoids in the gut20161677710.1089/can.2016.0001494013327413788Search in Google Scholar
Muccioli GG, Naslain D, Bäckhed F, Reigstad CS, Lambert DM, Delzenne NM, Cani PD. The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol. 2010; 6: 392.MuccioliGGNaslainDBäckhedFReigstadCSLambertDMDelzenneNMCaniPDThe endocannabinoid system links gut microbiota to adipogenesis2010639210.1038/msb.2010.46292552520664638Search in Google Scholar
Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007; 56, 1761–1772.CaniPDAmarJIglesiasMAPoggiMKnaufCBastelicaDNeyrinckAMFavaFTuohyKMChaboCMetabolic endotoxemia initiates obesity and insulin resistance2007561761177210.2337/db06-149117456850Search in Google Scholar
Xiao S, Fei N, Pang X, Shen J, Wang L, Zhang B, Zhang M, Zhang X, Zhang C, Li M, et al.: A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome. FEMS Microbiol Ecol. 2013; 87, 357–367.XiaoSFeiNPangXShenJWangLZhangBZhangMZhangXZhangCLiMA gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome20138735736710.1111/1574-6941.12228425529124117923Search in Google Scholar
Cani PD, Possemiers S, Van De Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck A, Lambert DM, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut. 2009; 58: 1091–1103.CaniPDPossemiersSVan De WieleTGuiotYEverardARottierOGeurtsLNaslainDNeyrinckALambertDMChanges in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability2009581091110310.1136/gut.2008.165886270283119240062Search in Google Scholar
Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, Guiot Y, Derrien M, Muccioli GG, Delzenne NM, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA. 2013; 110: 9066–9071.EverardABelzerCGeurtsLOuwerkerkJPDruartCBindelsLBGuiotYDerrienMMuccioliGGDelzenneNMCross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity20131109066907110.1073/pnas.1219451110367039823671105Search in Google Scholar
Depommier C, Everard A, Druart C, Plovier H, Van Hul M, Vieira-Silva S, Falony G, Raes J, Maiter D, Delzenne NM, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: A proof-of-concept exploratory study. Nat Med. 2019; 25: 1096–1103.DepommierCEverardADruartCPlovierHVan HulMVieira-SilvaSFalonyGRaesJMaiterDDelzenneNMSupplementation with Akkermansia muciniphila in overweight and obese human volunteers: A proof-of-concept exploratory study2019251096110310.1038/s41591-019-0495-2669999031263284Search in Google Scholar
Ciobârcă D, Cătoi AF, Copăescu C, Miere D, Crișan G. Bariatric surgery in obesity: Effects on gut microbiota and micronutrient status. Nutrients. 2020; 12: 235.CiobârcăDCătoiAFCopăescuCMiereDCrișanGBariatric surgery in obesity: Effects on gut microbiota and micronutrient status20201223510.3390/nu12010235701960231963247Search in Google Scholar
Guo Y, Liu CQ, Liu GP, Huang ZP, Zou DJ. Roux-en-Y gastric bypass decreases endotoxemia and inflammatory stress in association with improvements in gut permeability in obese diabetic rats. J Diabetes. 2019; 11: 786–793.GuoYLiuCQLiuGPHuangZPZouDJRoux-en-Y gastric bypass decreases endotoxemia and inflammatory stress in association with improvements in gut permeability in obese diabetic rats20191178679310.1111/1753-0407.1290630714321Search in Google Scholar
Morales-Marroquin E, Hanson B, Greathouse L, de la Cruz-Munoz N, Messiah SE. Comparison of methodological approaches to human gut microbiota changes in response to metabolic and bariatric surgery: A systematic review. Obes. Rev., 2020; 21: e13025.Morales-MarroquinEHansonBGreathouseLde la Cruz-MunozNMessiahSEComparison of methodological approaches to human gut microbiota changes in response to metabolic and bariatric surgery: A systematic review202021e1302510.1111/obr.1302532249534Search in Google Scholar
Aron-Wisnewsky J, Doré J, Clement K. The importance of the gut microbiota after bariatric surgery. Nat Rev Gastroenterol Hepatol. 2012; 9: 590–598.Aron-WisnewskyJDoréJClementKThe importance of the gut microbiota after bariatric surgery2012959059810.1038/nrgastro.2012.16122926153Search in Google Scholar
Wagner NRF, Zaparolli MR, Cruz MRR, Schieferdecker MEM, Campos ACL. Postoperative changes in intestinal microbiota and use of probiotics in Roux-En-Y gastric bypass and sleeve vertical gastrectomy: An integrative review. Arq Bras Cir Dig. 2018; 31: e1400.WagnerNRFZaparolliMRCruzMRRSchieferdeckerMEMCamposACLPostoperative changes in intestinal microbiota and use of probiotics in Roux-En-Y gastric bypass and sleeve vertical gastrectomy: An integrative review201831e140010.1590/0102-672020180001e1400628437330539975Search in Google Scholar
Duranti S, Ferrario C, van Sinderen D, Ventura M, Turroni F. Obesity and microbiota: An example of an intricate relationship. Genes Nutr. 2017; 12: 18.DurantiSFerrarioCvan SinderenDVenturaMTurroniFObesity and microbiota: An example of an intricate relationship2017121810.1186/s12263-017-0566-2547300028638490Search in Google Scholar
Wang W, Cheng Z, Wang Y, Dai Y, Zhang X, Hu S. Role of bile acids in bariatric surgery. Front Physiol. 2019; 10: 374.WangWChengZWangYDaiYZhangXHuSRole of bile acids in bariatric surgery20191037410.3389/fphys.2019.00374645439131001146Search in Google Scholar
Hankir MK, Langseder T, Bankoglu EE, Ghoreishi Y, Dischinger U, Kurlbaum M, Kroiss M, Otto C, le Roux CW, Arora T, et al. Simulating the post-gastric bypass intestinal microenvironment uncovers a barrier-stabilizing role for FXR. iScience, 2020; 23: 101777.HankirMKLangsederTBankogluEEGhoreishiYDischingerUKurlbaumMKroissMOttoCle RouxCWAroraTSimulating the post-gastric bypass intestinal microenvironment uncovers a barrier-stabilizing role for FXR20202310177710.1016/j.isci.2020.101777768955533294786Search in Google Scholar
Monte SV, Caruana JA, Ghanim H, Sia CL, Korzeniewski K, Schentag JJ, Dandona P. Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus. Surgery, 2012; 151: 587–593.MonteSVCaruanaJAGhanimHSiaCLKorzeniewskiKSchentagJJDandonaPReduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus201215158759310.1016/j.surg.2011.09.03822088821Search in Google Scholar
Yang PJ, Lee WJ, Tseng PH, Lee PH, Lin MT, Yang WS. Bariatric surgery decreased the serum level of an endotoxin-associated marker: Lipopolysaccharide-binding protein. Surg Obes Relat Dis. 2014; 10: 1182–1187.YangPJLeeWJTsengPHLeePHLinMTYangWSBariatric surgery decreased the serum level of an endotoxin-associated marker: Lipopolysaccharide-binding protein2014101182118710.1016/j.soard.2014.02.02224713521Search in Google Scholar
Mokhtari Z, Karbaschian Z, Pazouki A, Kabir A, Hedayati M, Mirmiran P. The effects of probiotic supplements on blood markers of endotoxin and lipid peroxidation in patients undergoing gastric bypass surgery; A randomized, double-blind, placebo-controlled, clinical trial with 13 months follow-up. Obes Surg. 2019; 29: 1248–1258.MokhtariZKarbaschianZPazoukiAKabirAHedayatiMMirmiranPThe effects of probiotic supplements on blood markers of endotoxin and lipid peroxidation in patients undergoing gastric bypass surgery; A randomized, double-blind, placebo-controlled, clinical trial with 13 months follow-up2019291248125810.1007/s11695-018-03667-630612325Search in Google Scholar
Clemente-Postigo M, Roca-Rodriguez MDM, Camargo A, Ocaña-Wilhelmi L, Cardona F, Tinahones FJ. Lipopolysaccharide and lipopolysaccharide-binding protein levels and their relationship to early metabolic improvement after bariatric surgery. Surg Obes Relat Dis. 2015; 11: 933–939.Clemente-PostigoMRoca-RodriguezMDMCamargoAOcaña-WilhelmiLCardonaFTinahonesFJLipopolysaccharide and lipopolysaccharide-binding protein levels and their relationship to early metabolic improvement after bariatric surgery20151193393910.1016/j.soard.2014.11.03025737102Search in Google Scholar
Trøseid M, Nestvold TK, Rudi K, Thoresen H, Nielsen EW, Lappegård KT. Plasma lipopolysaccharide is closely associated with glycemic control and abdominal obesity: Evidence from bariatric surgery. Diabetes Care, 2013; 36: 3627–3632.TrøseidMNestvoldTKRudiKThoresenHNielsenEWLappegårdKTPlasma lipopolysaccharide is closely associated with glycemic control and abdominal obesity: Evidence from bariatric surgery2013363627363210.2337/dc13-0451381687623835694Search in Google Scholar
Van Dielen FMH, Buurman WA, Hadfoune M, Nijhuis J, Greve JW. Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery. J Clin Endocrinol Metab. 2004; 89: 4062–4068.Van DielenFMHBuurmanWAHadfouneMNijhuisJGreveJWMacrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery2004894062406810.1210/jc.2003-03212515292349Search in Google Scholar
Li Y, Guan W, Ma S, Lin S, Yang N, Liu R, Liang H, Zhou H. Lipopolysaccharide and inflammatory cytokines levels decreased after sleeve gastrectomy in Chinese adults with obesity. Endocr J. 2019; 66: 337–347.LiYGuanWMaSLinSYangNLiuRLiangHZhouHLipopolysaccharide and inflammatory cytokines levels decreased after sleeve gastrectomy in Chinese adults with obesity20196633734710.1507/endocrj.EJ18-044630799316Search in Google Scholar
Blanchard C, Moreau F, Chevalier J, Ayer A, Garcon D, Arnaud L, Pais de Barros JP, Gautier T, Neunlist M, Cariou B, Le May C. Sleeve gastrectomy alters intestinal permeability in diet-induced obese mice. Obes Surg. 2017; 27: 2590–2598.BlanchardCMoreauFChevalierJAyerAGarconDArnaudLPais de BarrosJPGautierTNeunlistMCariouBLe MayCSleeve gastrectomy alters intestinal permeability in diet-induced obese mice2017272590259810.1007/s11695-017-2670-128429171Search in Google Scholar